KR0169319B1 - 서방성 정제 - Google Patents
서방성 정제 Download PDFInfo
- Publication number
- KR0169319B1 KR0169319B1 KR1019910011776A KR910011776A KR0169319B1 KR 0169319 B1 KR0169319 B1 KR 0169319B1 KR 1019910011776 A KR1019910011776 A KR 1019910011776A KR 910011776 A KR910011776 A KR 910011776A KR 0169319 B1 KR0169319 B1 KR 0169319B1
- Authority
- KR
- South Korea
- Prior art keywords
- sustained
- release
- water
- tablet
- pharmacologically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP90-197019 | 1990-07-25 | ||
| JP2197019A JP2572673B2 (ja) | 1990-07-25 | 1990-07-25 | 徐放性錠剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR930001899A KR930001899A (ko) | 1993-02-22 |
| KR0169319B1 true KR0169319B1 (ko) | 1999-01-15 |
Family
ID=16367420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910011776A Expired - Fee Related KR0169319B1 (ko) | 1990-07-25 | 1991-07-11 | 서방성 정제 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5164193A (enExample) |
| EP (1) | EP0468436B1 (enExample) |
| JP (1) | JP2572673B2 (enExample) |
| KR (1) | KR0169319B1 (enExample) |
| CA (1) | CA2046845C (enExample) |
| DE (1) | DE69128569T2 (enExample) |
| ES (1) | ES2111547T3 (enExample) |
| TW (1) | TW222592B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0818990A1 (en) * | 1995-04-03 | 1998-01-21 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
| US7179486B1 (en) | 1997-04-01 | 2007-02-20 | Nostrum Pharmaceuticals, Inc. | Process for preparing sustained release tablets |
| CA2216215A1 (en) | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
| FR2771292B1 (fr) * | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
| FR2771291B1 (fr) * | 1997-11-21 | 2000-02-25 | Ethypharm Lab Prod Ethiques | Spheroides, procede de preparation et compositions pharmaceutiques |
| GB9824893D0 (en) * | 1998-11-12 | 1999-01-06 | Smithkline Beckman Corp | Novel method of treatment |
| US20030153607A1 (en) * | 1998-11-12 | 2003-08-14 | Smithkline Beecham P.L.C. | Novel composition and use |
| CN100370967C (zh) * | 1999-06-04 | 2008-02-27 | 阿尔萨公司 | 埋植凝胶组合物及其制备方法 |
| JP2003508420A (ja) | 1999-09-02 | 2003-03-04 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | 経口投与に適した、制御された放出の経口用量 |
| US20050037073A1 (en) * | 2000-01-13 | 2005-02-17 | Alpharx Inc. | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof |
| WO2002067905A1 (en) * | 2001-02-27 | 2002-09-06 | Kos Pharmaceuticals, Inc. | A sustained release pharmaceutical formulation |
| KR100464592B1 (ko) * | 2001-04-13 | 2004-12-31 | 주식회사 한국팜비오 | 포타슘시트레이트를 함유한 왁스 매트릭스 타입의 정제와그의 조성물 |
| CA2452874A1 (en) * | 2001-07-06 | 2003-01-16 | Endo Pharmaceuticals, Inc. | Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| US8329216B2 (en) | 2001-07-06 | 2012-12-11 | Endo Pharmaceuticals Inc. | Oxymorphone controlled release formulations |
| US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
| RU2190408C1 (ru) * | 2001-10-16 | 2002-10-10 | Нестерук Владимир Викторович | Лекарственное средство на основе пентоксифиллина |
| HRP20020124A2 (en) * | 2002-02-11 | 2003-10-31 | Pliva D D | Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
| US20050031686A1 (en) * | 2002-03-25 | 2005-02-10 | Truffini & Regge' Farmaceutici Srl | Gastroresistant tablets for alimentary, dietetic and therapeutic use |
| US8158149B2 (en) * | 2004-05-12 | 2012-04-17 | Chelsea Therapeutics, Inc. | Threo-DOPS controlled release formulation |
| US20060105036A1 (en) | 2003-05-12 | 2006-05-18 | Stephen Peroutka | Threo-dops controlled release formulation |
| US20050220877A1 (en) * | 2004-03-31 | 2005-10-06 | Patel Ashish A | Bilayer tablet comprising an antihistamine and a decongestant |
| EP1830886B1 (en) | 2004-12-27 | 2016-04-13 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| US20090060993A1 (en) * | 2007-09-04 | 2009-03-05 | Joseph Schwarz | Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones |
| JP5122380B2 (ja) * | 2008-06-16 | 2013-01-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 薬物の放出を制御した速崩錠及びその製法 |
| US8962020B2 (en) * | 2012-07-26 | 2015-02-24 | Glycadia Inc. | Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid |
| CN109219442A (zh) | 2016-04-04 | 2019-01-15 | Omeza有限公司 | 鱼油局部组合物 |
| US10377708B2 (en) | 2017-12-05 | 2019-08-13 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| EP3720434A4 (en) | 2017-12-05 | 2021-09-01 | Sunovion Pharmaceuticals Inc. | NON-RACEMIC MIXTURES AND THEIR USE |
| CN114401717A (zh) | 2019-06-04 | 2022-04-26 | 赛诺维信制药公司 | 修饰释放配制品及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56122311A (en) * | 1980-02-29 | 1981-09-25 | Eisai Co Ltd | Lasting theophylline pharmaceutical composition |
| JPS5883613A (ja) * | 1981-11-10 | 1983-05-19 | Toa Eiyou Kagaku Kogyo Kk | 硝酸イソソルビト−ル製剤 |
| JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
| US4863744A (en) * | 1984-09-17 | 1989-09-05 | Alza Corporation | Intestine drug delivery |
| GB8521494D0 (en) * | 1985-08-29 | 1985-10-02 | Zyma Sa | Controlled release tablet |
| IT1200178B (it) * | 1986-07-23 | 1989-01-05 | Alfa Farmaceutici Spa | Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica |
| IT1215726B (it) * | 1988-01-18 | 1990-02-22 | Alfa Wassermann Spa | Formulazioni galeniche a cessione programmata. |
| IT1237904B (it) * | 1989-12-14 | 1993-06-18 | Ubaldo Conte | Compresse a rilascio a velocita' controllata delle sostanze attive |
| IT1241417B (it) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
-
1990
- 1990-07-25 JP JP2197019A patent/JP2572673B2/ja not_active Expired - Lifetime
-
1991
- 1991-07-11 KR KR1019910011776A patent/KR0169319B1/ko not_active Expired - Fee Related
- 1991-07-11 CA CA002046845A patent/CA2046845C/en not_active Expired - Fee Related
- 1991-07-19 US US07/732,927 patent/US5164193A/en not_active Expired - Fee Related
- 1991-07-20 TW TW080105645A patent/TW222592B/zh active
- 1991-07-23 DE DE69128569T patent/DE69128569T2/de not_active Expired - Fee Related
- 1991-07-23 ES ES91112313T patent/ES2111547T3/es not_active Expired - Lifetime
- 1991-07-23 EP EP91112313A patent/EP0468436B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0468436B1 (en) | 1998-01-07 |
| DE69128569D1 (de) | 1998-02-12 |
| KR930001899A (ko) | 1993-02-22 |
| CA2046845C (en) | 2001-03-27 |
| EP0468436A1 (en) | 1992-01-29 |
| TW222592B (enExample) | 1994-04-21 |
| US5164193A (en) | 1992-11-17 |
| JPH0482825A (ja) | 1992-03-16 |
| JP2572673B2 (ja) | 1997-01-16 |
| ES2111547T3 (es) | 1998-03-16 |
| CA2046845A1 (en) | 1992-01-26 |
| DE69128569T2 (de) | 1998-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0169319B1 (ko) | 서방성 정제 | |
| KR100305234B1 (ko) | 장내목표부위에서의약적유효성분을방출하도록조정된약학적제제 | |
| JP2916978B2 (ja) | 放出開始制御型製剤 | |
| KR100203339B1 (ko) | 의약용 방출조절 매트릭스 | |
| KR100371523B1 (ko) | 테오필린 서방성 정제 | |
| DE69629797T2 (de) | Matrix zur gesteuerten freisetzung von arzneistoffen | |
| FI113336B (fi) | Menetelmä tramadolisuolaa sisältävän lääkeaineen valmistamiseksi, jolla on viivästynyt vaikuttavan aineen vapautuminen | |
| US5472704A (en) | Pharmaceutical controlled-release composition with bioadhesive properties | |
| JP2519296B2 (ja) | イブプロフェン除放性錠剤及びその製造方法 | |
| US20110071137A1 (en) | Process for preparing sustained release tablets | |
| JP2002533380A (ja) | 多孔性粒子を含む剤形 | |
| WO1999051209A1 (en) | Press coated, pulsatile drug delivery system suitable for oral administration | |
| IE880855L (en) | Slow-release pharmaceutical agent | |
| US6437000B1 (en) | Controlled release oral dosage for suitable for oral administration | |
| CN105832687A (zh) | 包含氢吗啡酮和纳洛酮的药物组合物 | |
| DE69119217T2 (de) | Zusammensetzungen zur kontrollierten freigabe | |
| AU662403B2 (en) | Stabilized solid pharmaceutical preparation and method of producing the same | |
| JP2004527458A5 (enExample) | ||
| TWI282737B (en) | Sustained release oral preparations | |
| JPH04273816A (ja) | パルス放出型有核錠 | |
| JP2006514672A (ja) | 疎水性物質を徐放剤として含有する制御性放出製剤 | |
| JP2003146882A (ja) | 生理活性物質含有固形物の溶出速度を制御する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-5-5-R10-R13-asn-PN2301 St.27 status event code: A-5-5-R10-R11-asn-PN2301 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| FPAY | Annual fee payment |
Payment date: 20030923 Year of fee payment: 6 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20041011 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20041011 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |